$INM
InMed Pharmaceuticals Inc. Common Shares
XNAS•Health Care•Pharmaceutical Preparations
$1.38
▲+1.47%+$0.020
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateInMed Pharmaceuticals Inc. Common Shares
XNAS•Health Care•Pharmaceutical Preparations
Why is INM up today? It is at $1.38 (+1.47%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment INM spikes, and full due diligence on INM — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $INM 2 times in the last 30 days. Create a free account to track $INM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on INM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystMerger / acquisition agreement, from the latest SEC filing. Read it →Across every filing on file, supply equal to at least 43.8% of the tradeable float is in play - 43.8% more can still be issued.
Some filings did not state a size, so these are floors.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
1,213,648 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $1.2M in size · Priced at $0.67/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +8K 0.2% of company | added 0.9% | 892K | $11K at $1.29 | Sep 16, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +54K 1.0% of company | added 6.5% | 884K | $71K at $1.30 | Sep 15, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +29K 0.5% of company | added 3.6% | 830K | $37K at $1.29 | Sep 14, 26 |
Vivo Opportunity, Llc Beneficial Owner (10%) | Bought (open market) | +21 | added <0.1% | 818K | $33 at $1.55 | Jul 16, 26 |
Vivo Opportunity, Llc Beneficial Owner (10%) | Bought (open market) | +15K 0.3% of company | added 2.1% | 743K | $23K at $1.55 | Jul 15, 26 |
Adar1 Capital Management, Llc Beneficial Owner (10%) | Bought (open market) | +1K 0.02% of company | added 0.1% | 801K | $2K at $1.55 | Jul 15, 26 |
Vivo Opportunity, Llc Beneficial Owner (10%) | Bought (open market) | +5K 0.10% of company | added 0.7% | 729K | $8K at $1.55 | Jul 14, 26 |
Vivo Opportunity, Llc Beneficial Owner (10%) | Bought (open market) | +2K 0.03% of company | added 0.2% | 798K | $2K at $1.55 | Jul 2, 26 |
Vivo Opportunity, Llc Beneficial Owner (10%) | Bought (open market) | +4K 0.08% of company | added 0.6% | 723K | $7K at $1.55 | Jul 1, 26 |
Vivo Opportunity, Llc Beneficial Owner (10%) | Bought (open market) | +600 0.01% of company | added <0.1% | 719K | $924 at $1.54 | Jun 30, 26 |
Vivo Opportunity, Llc Beneficial Owner (10%) | Bought (open market) | +33K 0.6% of company | added 4.3% | 791K | $49K at $1.52 | Jun 8, 26 |
Vivo Opportunity, Llc Beneficial Owner (10%) | Bought (open market) | +55K 1.0% of company | added 8.7% | 689K | $86K at $1.57 | Jun 5, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on INM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
INM last traded at $1.38, up 1.47% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
InMed Pharmaceuticals Inc. Common Shares (INM) is next expected to report earnings on Thursday, November 5, 2026, about 45 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The INM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged INM 2 times in the last 30 days.
INM (InMed Pharmaceuticals Inc. Common Shares) trades on XNAS, with a market cap of about $8M in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge INM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$INM discussion
Sign in to ask a question or join the discussion.